Epic, LabCorp Team on Sample Prep for Clinical Trials | GenomeWeb

NEW YORK (GenomeWeb News) – Circulating tumor cell-based diagnostics firm Epic Sciences today announced an agreement with Laboratory Corporation of America aimed at speeding up sample processing for Epic's technology in support of European clinical trials.

LabCorp's Central Laboratory in Mechelen, Belgium will process samples for Epic's clinical trial partners and customers as part of the deal. The samples will then be sent to Epic's laboratory in La Jolla, Calif. for downstream detection and molecular characterization of CTCs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.